Posts Categorized as: Migraine
With the Migraine Research Foundation reporting that migraines affect 38 million adults and children in the United States (more than asthma and diabetes put together), it's no surprise that Dr. Helton sees a lot of headache patients in our Portland office. While some folks choose to relieve migraine pain with drugs, chiropractic is a terrific, all-natural alternative that usually provides positive results.
For example, one report published in the Journal of Manipulative and Physiological Therapeutics involved 127 people ranging in age from 10 to 70-years-old who struggled with regular (at least monthly) migraines. Each subject engaged in up to 16 chiropractic sessions. The subjects noted that their headache frequency, duration, and disability two months before the study began, during the duration of the sessions (which was two months), and two months post-treatment.
What the investigators discovered is that spinal manipulation therapy reduced the frequency, duration, and disability of the migraine headaches when compared with the control patients who didn't receive chiropractic. Furthermore, this enabled them to take less medication for the pain, offering them an all-natural solution for a chronic condition.
Another article found that a combination of chiropractic and neck massage reduced migraine headaches almost 68%.
If you have migraine pain and are looking for relief, call Dr. Helton today and request an appointment in our Portland chiropractic office. We'll do what we can to help you become pain-free!
Migraine Fact Sheet. Migraine Research Foundation. Retrieved from http://www.migraineresearchfoundation.org/fact-sheet.html on November 2, 2015
Noudeh Y et al. (2012). Reduction of current migraine headache pain following neck massage and spinal manipulation. International Journal of Therapeutic Massage & Bodywork;5(1):5-13
Tuchin P et al. (2000, February). A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics;23(2):91-5